Nephrology

REACH is an experienced thought leader in the nephrology space. Our team has conducted research across many nephrological diseases, both rare and non-rare.

DISEASES WE COVER

Nephrology has evolved from one-size-all treatments to a rich pipeline targeting the many diverse causes of Chronic Kidney Disease (CKD). Current nephrology dynamics the REACH team is tracking include:

  • Nephrology conditions with high unmet need for FDA approved treatments (e.g., Membranous Nephropathy, FSGS, C3G and Alport Syndrome)
  • ACE/ARBs will continue to be the foundation of treatment, and new therapies will be utilized as add-ons to RAS blockade
  • New therapies receiving accelerated approval based on proteinuria reduction, however demonstrating improved kidney function over a longer time period, has been a challenging bar to clear (e.g., Travere’s sparsentan in IgAN and FSGS)
See our rare nephrology solutions

Search Nephrology diseases we cover

Disease
Alport Syndrome
Alport Syndrome
Complement 3 Glomerulopathy
Complement 3 Glomerulopathy
Focal Segmental Glomerulosclerosis
Focal Segmental Glomerulosclerosis
Goodpasture’s Syndrome
Goodpasture’s Syndrome
Henoch-Schönlein Purpura / IgA Vasculitis
Henoch-Schönlein Purpura / IgA Vasculitis
IgA Nephropathy
IgA Nephropathy
Lupus Nephritis
Lupus Nephritis
Membranous Nephropathy
Membranous Nephropathy
Primary Hyperoxaluria Type 1
Primary Hyperoxaluria Type 1
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Disease
Alport Syndrome
Alport Syndrome
Complement 3 Glomerulopathy
Complement 3 Glomerulopathy
Focal Segmental Glomerulosclerosis
Focal Segmental Glomerulosclerosis
Don’t see your disease of interest? Don’t worry! Our experienced team can provide market research support for any rare disease. Reach out to learn how we can help.
Browse contacts:
1 2 3

Schedule a nephrology demo with our team

OUR SOLUTIONS

Market Landscape Assessment

MarketVue® reports capture the current and anticipated future state of any rare nephrology market

Learn More

Epidemiology

EpiVue® reports quantify prevalence, diagnosis, treatment rates and patient segments for rare nephrological conditions

Learn More

Indication Prioritization

MarketSheet® single-sheet market primers for any nephrology disease allow easy comparison across the nephrology therapy area

Learn More

Custom Rapid Insights

Fast turnaround primary market research for a focused set of questions for nephrologists or payers

Learn More

Reach out to our team to learn more about our capabilities and view sample reports.

Contact us